New window of opportunity with ICIs in melanoma
- PMID: 30410079
- DOI: 10.1038/s41571-018-0124-x
New window of opportunity with ICIs in melanoma
Comment on
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.Nat Med. 2018 Nov;24(11):1649-1654. doi: 10.1038/s41591-018-0197-1. Epub 2018 Oct 8. Nat Med. 2018. PMID: 30297909 Free PMC article. Clinical Trial.
-
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.Nat Med. 2018 Nov;24(11):1655-1661. doi: 10.1038/s41591-018-0198-0. Epub 2018 Oct 8. Nat Med. 2018. PMID: 30297911 Clinical Trial.
Similar articles
-
Neoadjuvant therapy for melanoma: is it ready for prime time?Lancet Oncol. 2019 Jul;20(7):892-894. doi: 10.1016/S1470-2045(19)30377-8. Epub 2019 Jun 3. Lancet Oncol. 2019. PMID: 31171445 No abstract available.
-
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.Nat Med. 2018 Nov;24(11):1655-1661. doi: 10.1038/s41591-018-0198-0. Epub 2018 Oct 8. Nat Med. 2018. PMID: 30297911 Clinical Trial.
-
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27. Lancet Oncol. 2018. PMID: 29602646 Clinical Trial.
-
Nivolumab monotherapy or in combination with ipilimumab for metastatic melanoma: systematic review and meta-analysis of randomized-controlled trials.Melanoma Res. 2018 Oct;28(5):371-379. doi: 10.1097/CMR.0000000000000467. Melanoma Res. 2018. PMID: 29957656
-
Nivolumab in melanoma.Expert Rev Anticancer Ther. 2016 Dec;16(12):1247-1261. doi: 10.1080/14737140.2016.1249856. Epub 2016 Nov 7. Expert Rev Anticancer Ther. 2016. PMID: 27776441 Review.
Cited by
-
Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability.Front Cell Dev Biol. 2021 Feb 12;9:618313. doi: 10.3389/fcell.2021.618313. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33644056 Free PMC article.
-
Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic 'Choosing Wisely' campaign: a narrative review.Transl Cancer Res. 2020 Nov;9(11):7337-7349. doi: 10.21037/tcr-20-2343. Transl Cancer Res. 2020. PMID: 33354523 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical